Geode Capital Management’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$583K Sell
816,915
-1,072,357
-57% -$766K ﹤0.01% 3503
2025
Q1
$1.23M Buy
1,889,272
+35,255
+2% +$22.9K ﹤0.01% 3233
2024
Q4
$3.41M Sell
1,854,017
-2,939
-0.2% -$5.41K ﹤0.01% 2928
2024
Q3
$6.43M Buy
1,856,956
+132,015
+8% +$457K ﹤0.01% 2630
2024
Q2
$5.05M Buy
1,724,941
+438,625
+34% +$1.29M ﹤0.01% 2712
2024
Q1
$7.27M Buy
1,286,316
+27,079
+2% +$153K ﹤0.01% 2510
2023
Q4
$5.4M Buy
1,259,237
+62,085
+5% +$266K ﹤0.01% 2662
2023
Q3
$4.15M Buy
1,197,152
+35,620
+3% +$124K ﹤0.01% 2734
2023
Q2
$5.4M Buy
1,161,532
+105,218
+10% +$489K ﹤0.01% 2642
2023
Q1
$4.88M Buy
1,056,314
+35,235
+3% +$163K ﹤0.01% 2634
2022
Q4
$8.25M Buy
1,021,079
+170,332
+20% +$1.38M ﹤0.01% 2386
2022
Q3
$4.72M Buy
850,747
+35,958
+4% +$200K ﹤0.01% 2709
2022
Q2
$4.25M Buy
814,789
+25,993
+3% +$135K ﹤0.01% 2793
2022
Q1
$6.48M Buy
788,796
+45,117
+6% +$371K ﹤0.01% 2638
2021
Q4
$11.1M Buy
743,679
+51,703
+7% +$769K ﹤0.01% 2375
2021
Q3
$13.1M Buy
691,976
+14,270
+2% +$270K ﹤0.01% 2267
2021
Q2
$12.6M Buy
677,706
+111,057
+20% +$2.06M ﹤0.01% 2296
2021
Q1
$12.9M Buy
566,649
+148,130
+35% +$3.37M ﹤0.01% 2175
2020
Q4
$9.09M Buy
418,519
+98,035
+31% +$2.13M ﹤0.01% 2240
2020
Q3
$3.22M Buy
320,484
+58,162
+22% +$584K ﹤0.01% 2632
2020
Q2
$2.04M Buy
262,322
+142,869
+120% +$1.11M ﹤0.01% 2825
2020
Q1
$1.22M Buy
119,453
+23,237
+24% +$237K ﹤0.01% 2929
2019
Q4
$1.06M Buy
96,216
+3,841
+4% +$42.2K ﹤0.01% 3260
2019
Q3
$839K Buy
92,375
+582
+0.6% +$5.29K ﹤0.01% 3287
2019
Q2
$1.04M Buy
91,793
+38,173
+71% +$434K ﹤0.01% 3231
2019
Q1
$610K Buy
53,620
+3,019
+6% +$34.3K ﹤0.01% 3354
2018
Q4
$456K Buy
+50,601
New +$456K ﹤0.01% 3406